Product Name: Human PDGFRA Antibody (Olaratumab, Research Use)
Catalog Number: NBR-0266
Target Name: PDGFRA
Trade Name: Olaratumab
Antibody Drug Description: Olaratumab is a platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: PDGFRA
Synonyms: CD140a; GAS9; PDGFR2
Target Description: Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration.
Ensembl: ENSG00000134853 
Uniprot: P16234